4.7 Article

The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective A Review

Massimo Filippi et al.

Summary: This narrative review discusses the clinical application of magnetic resonance imaging in progressive multiple sclerosis for diagnosis and prognosis. It highlights the importance of using MRI to diagnose primary progressive MS and identify RRMS patients at risk of developing secondary progressive MS.

JAMA NEUROLOGY (2021)

Article Clinical Neurology

2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

Mike P. Wattjes et al.

Summary: The 2021 revision of guidelines on MRI use for multiple sclerosis patients integrates recommendations from various organizations to improve the application of MRI for diagnosis, prognosis, and monitoring of individuals with multiple sclerosis. It suggests changes in MRI acquisition protocols, cautious use of gadolinium-based contrast agents, and extends recommendations to the use of MRI in children, during pregnancy, and in the post-partum period for patients with multiple sclerosis.

LANCET NEUROLOGY (2021)

Article Clinical Neurology

Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis

Luca Prosperini et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Review Clinical Neurology

The 2013 clinical course descriptors for multiple sclerosis A clarification

Fred D. Lublin et al.

NEUROLOGY (2020)

Review Clinical Neurology

Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis

Dalia Rotstein et al.

NATURE REVIEWS NEUROLOGY (2019)

Article Clinical Neurology

Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis

Wallace J. Brownlee et al.

BRAIN (2019)

Review Clinical Neurology

Unraveling treatment response in multiple sclerosis A clinical and MRI challenge

Claudio Gasperini et al.

NEUROLOGY (2019)

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Article Clinical Neurology

Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging - Yes

Rosa Cortese et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Article Clinical Neurology

Contents

Multiple Sclerosis Journal (2018)

Review Clinical Neurology

NEDA treatment target? No evident disease activity as an actionable outcome in practice

Natalie E. Parks et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Article Clinical Neurology

Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis

C. Zecca et al.

MULTIPLE SCLEROSIS JOURNAL (2016)

Article Clinical Neurology

Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis

C. Zecca et al.

MULTIPLE SCLEROSIS JOURNAL (2016)

Review Clinical Neurology

Brain health: time matters in multiple sclerosis

Gavin Giovannoni et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)

Review Clinical Neurology

Spinal cord MRI in multiple sclerosis-diagnostic, prognostic and clinical value

Hugh Kearney et al.

NATURE REVIEWS NEUROLOGY (2015)

Editorial Material Clinical Neurology

Disease Activity Free Status A New End Point for a New Era in Multiple Sclerosis Clinical Research?

Carolyn J. Bevan et al.

JAMA NEUROLOGY (2014)

Review Clinical Neurology

Defining and scoring response to IFN-β in multiple sclerosis

Maria Pia Sormani et al.

NATURE REVIEWS NEUROLOGY (2013)

Article Clinical Neurology

Freedom from disease activity in multiple sclerosis

Eva Havrdova et al.

NEUROLOGY (2010)